Globus Medical (GMED) reported Q1 non-GAAP earnings late Thursday of $0.68 per diluted share, up from $0.63 a year earlier.
Two analysts polled by FactSet, on average, expected $0.77.
Net sales for the quarter ended March 31 fell to $598.1 million from $606.7 million a year earlier.
Analysts expected $625.9 million.
For 2025, the company said it cut its non-GAAP EPS outlook to $3 to $3.30 from $3.10 to $3.40 previously and reaffirmed revenue guidance in the range of $2.80 billion to $2.90 billion.
Analysts are looking for $3.28 and $2.68 billion, respectively.
Shares of Globus Medical fell more than 16% in Thursday's after-hours session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.